Huntington National Bank Grows Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Huntington National Bank increased its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 21.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,280 shares of the financial services provider’s stock after purchasing an additional 226 shares during the quarter. Huntington National Bank’s holdings in iShares Biotechnology ETF were worth $169,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. FMR LLC grew its holdings in shares of iShares Biotechnology ETF by 19.2% in the third quarter. FMR LLC now owns 14,450 shares of the financial services provider’s stock worth $2,104,000 after acquiring an additional 2,332 shares during the period. Townsquare Capital LLC increased its position in shares of iShares Biotechnology ETF by 10.1% during the 3rd quarter. Townsquare Capital LLC now owns 1,683 shares of the financial services provider’s stock valued at $245,000 after purchasing an additional 154 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new position in shares of iShares Biotechnology ETF in the 3rd quarter worth approximately $2,941,000. Benjamin Edwards Inc. purchased a new position in shares of iShares Biotechnology ETF in the third quarter worth approximately $244,000. Finally, Quantinno Capital Management LP bought a new stake in iShares Biotechnology ETF during the third quarter valued at approximately $244,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

NASDAQ:IBB opened at $117.16 on Friday. iShares Biotechnology ETF has a one year low of $117.02 and a one year high of $150.57. The business has a fifty day moving average price of $134.95 and a 200-day moving average price of $138.11. The firm has a market capitalization of $5.27 billion, a price-to-earnings ratio of 24.21 and a beta of 0.82.

iShares Biotechnology ETF Increases Dividend

The business also recently declared a dividend, which was paid on Friday, March 21st. Shareholders of record on Tuesday, March 18th were given a $0.1212 dividend. This is a boost from iShares Biotechnology ETF’s previous dividend of $0.06. The ex-dividend date of this dividend was Tuesday, March 18th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.